Clal Biotechnology Industries Ltd (CBI) — Long-term Investment Intensity
Clal Biotechnology Industries Ltd (CBI) has a Long-term Investment Intensity of 25.3% as of September 2019. Long-term investments of ILA167.61 Million represent 25.3% of total assets of ILA662.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check CBI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Clal Biotechnology Industries Ltd Long-term Investment Intensity (2013–2018)
This chart shows how Clal Biotechnology Industries Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 25.3%, reflecting long-term investments of ILA167.61 Million against total assets of ILA662.69 Million ILA. For the complete balance sheet picture, see CBI asset base.
Annual Long-term Investment Intensity for Clal Biotechnology Industries Ltd (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Clal Biotechnology Industries Ltd from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Clal Biotechnology Industries Ltd carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 20.6% | ILA208.96 Million | ILA1.02 Billion | ▲ +1.0 pp |
| 2017 | 19.6% | ILA202.38 Million | ILA1.03 Billion | ▲ +4.8 pp |
| 2016 | 14.7% | ILA164.84 Million | ILA1.12 Billion | ▲ +3.9 pp |
| 2015 | 10.8% | ILA165.85 Million | ILA1.53 Billion | ▲ +0.5 pp |
| 2014 | 10.3% | ILA174.09 Million | ILA1.69 Billion | ▲ +3.5 pp |
| 2013 | 6.9% | ILA131.65 Million | ILA1.92 Billion | — |